Efficacy of SMTP ‐7, a small‐molecule anti‐inflammatory thrombolytic, in embolic stroke in monkeys-Reference-Cited by-同舟云学术

Efficacy of SMTP ‐7, a small‐molecule anti‐inflammatory thrombolytic, in embolic stroke in monkeys

Published:2018-12 Issue:6 Volume:6 Page:e00448
ISSN:2052-1707
Container-title:Pharmacology Research & Perspectives
language:en
Short-container-title:Pharmacol Res Perspect

Author:

Suzuki Eriko¹,Nishimura Naoko²,Yoshikawa Tetsuya³,Kunikiyo Yudai¹,Hasegawa Keiko²,Hasumi Keiji¹²^ORCID

Affiliation:

1. Department of Applied Biological Science Tokyo Noko University (Tokyo University of Agriculture and Technology) Tokyo Japan

2. Division of Research and Development TMS Co., Ltd. Tokyo Japan

3. Shin Nippon Biomedical Laboratories, Ltd. Kagoshima Japan

Funder

Japan Science and Technology Agency

Ministry of Education, Culture, Sports, Science and Technology

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/prp2.448

Reference42 articles.

1. Thrombolytic therapies for ischemic stroke: Triumphs and future challenges

2. Current perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic stroke;Chapman SN;Vasc Health Risk Manag,2014

3. Role of Tissue Plasminogen Activator in Acute Ischemic Stroke

4. How to make better use of thrombolytic therapy in acute ischemic stroke

5. Ischemia-Reperfusion Injury in Stroke

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engineering Hydrogels for Affinity-Based Release of Therapeutic Proteins;Chemistry of Materials;2024-01-04

2. Discovery and current developments of isoindolinone-based fungal natural products;European Journal of Medicinal Chemistry Reports;2023-12

3. Development, validation and application of a capillary microsampling LC–MS/MS method for the quantification of BIIB131 (SMTP-7) in rat plasma;Journal of Pharmaceutical and Biomedical Analysis;2023-11

4. Reperfusion and cytoprotective agents are a mutually beneficial pair in ischaemic stroke therapy: an overview of pathophysiology, pharmacological targets and candidate drugs focusing on excitotoxicity and free radical;Stroke and Vascular Neurology;2023-10-13

5. SMTP-44D Inhibits Atherosclerotic Plaque Formation in Apolipoprotein-E Null Mice Partly by Suppressing the AGEs-RAGE Axis;International Journal of Molecular Sciences;2023-03-30